scispace - formally typeset
Open AccessJournal ArticleDOI

Evidence that production and release of amyloid beta-protein involves the endocytic pathway.

Edward H. Koo, +1 more
- 01 Jul 1994 - 
- Vol. 269, Iss: 26, pp 17386-17389
Reads0
Chats0
TLDR
It is hypothesized that the internalization of cell surface amyloid precursor protein (beta PP) via coated pit-mediated endocytosis is one pathway leading to A beta generation and release into medium.
About
This article is published in Journal of Biological Chemistry.The article was published on 1994-07-01 and is currently open access. It has received 1031 citations till now. The article focuses on the topics: Senile plaques & Amyloid precursor protein.

read more

Citations
More filters
Journal ArticleDOI

Alzheimer's Disease: Genes, Proteins, and Therapy

TL;DR: Evidence that the presenilin proteins, mutations in which cause the most aggressive form of inherited AD, lead to altered intramembranous cleavage of the beta-amyloid precursor protein by the protease called gamma-secretase has spurred progress toward novel therapeutics and provided discrete biochemical targets for drug screening and development.
Journal ArticleDOI

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Denise Harold, +86 more
- 01 Oct 2009 - 
TL;DR: A two-stage genome-wide association study of Alzheimer's disease involving over 16,000 individuals, the most powerful AD GWAS to date, produced compelling evidence for association with Alzheimer's Disease in the combined dataset.
Journal ArticleDOI

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

TL;DR: The results indicate that the two transmembrane aspartate residues are critical for both presenilin-1 endoproteolysis and γ-secretase activity, and suggest that presenILin 1 is either a unique diaspartyl cofactor for ιsecretase or is itselfγ- secretase, an autoactivated intramembranous aspartyl protease.
Journal ArticleDOI

Intracellular amyloid-β in Alzheimer's disease

TL;DR: Although the classical view is that Aβ is deposited extracellularly, emerging evidence from transgenic mice and human patients indicates that this peptide can also accumulate intraneuronally, which may contribute to disease progression.
References
More filters
Journal ArticleDOI

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

TL;DR: An apparently full-length complementary DNA clone coding for the A4 polypeptide is isolated and sequenced and suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Journal ArticleDOI

Amyloid β-peptide is produced by cultured cells during normal metabolism

TL;DR: The unexpected identification of the 4K (Mr 4,000) Aβ and a truncated form of Aβ in media from cultures of primary cells and untransfected and β-APP-transfected cell lines grown under normal conditions provide the basis for using simple cell culture systems to identify drugs that block the formation or release of A β, the primary protein constituent of the senile plaques of Alzheimer's disease.
Journal ArticleDOI

Production of the Alzheimer amyloid β protein by normal proteolytic processing

TL;DR: Human mononuclear leukemic cells expressing a beta AP-bearing, carboxyl-terminal beta APP derivative released significant amounts of a soluble 4-kilodalton beta AP derivative essentially identical to the beta AP deposited in Alzheimer's disease.
Journal ArticleDOI

Cleavage of amyloid beta peptide during constitutive processing of its precursor

TL;DR: Direct protein structural analyses showed that constitutive processing in human embryonic kidney 293 cells cleaves APP in the interior of the A Beta P, thus preventing A beta P deposition.
Journal ArticleDOI

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein

TL;DR: To study the putative precursor proteins of Alzheimer's disease A4 amyloid protein, polyclonal and monoclonal antibodies were raised against a recombinant bacterial PreA4(695) fusion protein to identify the precursors in different cell lines as well as in human brain homogenates and cerebrospinal fluid.
Related Papers (5)